FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ramesh Ramanathan

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Michael T Barrett; Lukas Bubendorf; Lisa Evers; Tara Holley; Elizabeth Lenkiewicz; Ramesh K Ramanathan; Christian Ruiz; Aleksander Sekulic; Daniel D Von Hoff
Clonal evolution and therapeutic resistance in solid tumors.
Glen J Weiss; Lisa Blaydorn; Mitesh J Borad; Marina Ciomei; francesco Fiorentini; Manuel Hidalgo; Jeffrey D Isaacs; Gayle Jameson; Antonio Jimeno; Daniel Laheru; Maria Adele Pacciarini; Ramesh K Ramanathan; Angela Scaburri; Raoul Tibes; Daniel D Von Hoff
Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies.
Patricia M LoRusso; Sridhar Mani; Daniel Mulkerin; Rachel Neuwirth; Ramesh K Ramanathan; Michelle A Rudek; John Sarantopoulos; Stephen I Shibata; Chris H Takimoto; Karthik Venkatakrishnan; Afshin Dowlati; Dixie Esseltine; Anne Hamilton; Percy Ivy
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ramesh Ramanathan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael T Barrett; Lukas Bubendorf; Lisa Evers; Tara Holley; Elizabeth Lenkiewicz; Ramesh K Ramanathan; Christian Ruiz; Aleksander Sekulic; Daniel D Von Hoff
Clonal evolution and therapeutic resistance in solid tumors.
Frontiers in pharmacology 2013;4():2.
2012: Glen J Weiss; Lisa Blaydorn; Mitesh J Borad; Marina Ciomei; francesco Fiorentini; Manuel Hidalgo; Jeffrey D Isaacs; Gayle Jameson; Antonio Jimeno; Daniel Laheru; Maria Adele Pacciarini; Ramesh K Ramanathan; Angela Scaburri; Raoul Tibes; Daniel D Von Hoff
Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies.
Investigational new drugs 2012;30(6):2334-43.
2012: Patricia M LoRusso; Sridhar Mani; Daniel Mulkerin; Rachel Neuwirth; Ramesh K Ramanathan; Michelle A Rudek; John Sarantopoulos; Stephen I Shibata; Chris H Takimoto; Karthik Venkatakrishnan; Afshin Dowlati; Dixie Esseltine; Anne Hamilton; Percy Ivy
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(10):2954-63.
2012: Benedito A Carneiro; Theodore L Crandall; Marwan G Fakih; Smitha S Krishnamurthi; Stewart L Lancaster; Barry C Lembersky; Richard A Pinkerton; Douglas M Potter; Ramesh K Ramanathan; Amy R Schmotzer; Ronald G Stoller; Nathan Bahary
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.
Clinical colorectal cancer 2012;11(1):53-9.
2012: Huali Wu; Beth A Zamboni; Yung-Jue Bang; Chandra P Belani; Robert P Edwards; David M Friedland; Lauren J Maruca; Suresh Ramalingam; Ramesh K Ramanathan; Ronald G Stoller; Sandra Strychor; William C Zamboni
Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients.
International journal of nanomedicine 2012;7():5555-64.
2012: Mitesh J Borad; Kelly K Curtis; Amylou Dueck; Gayle Jameson; Ramesh K Ramanathan; Raoul Tibes; Hani M Babiker; Martin Benjamin; Karen Wright; Daniel D Von Hoff
The impact of concomitant medication use on patient eligibility for phase I cancer clinical trials.
Journal of Cancer 2012;3():345-53.
2011: Ticiana B Leal; Heinz-Josef Lenz; Patricia M LoRusso; Sridhar Mani; James Mier; Angela Davies; Merrill J Egorin; Anne Hamilton; S Percy Ivy; Rachel Neuwirth; Ramesh K Ramanathan; Scot C Remick; John Sarantopoulos; Stephen Shibata; Chris H Takimoto; Karthik Venkatakrishnan; Lisa von Moltke; John J Wright; Daniel Mulkerin
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.
Cancer chemotherapy and pharmacology 2011;68(6):1439-47.
2011: Rajul K Jain; Candace S Johnson; Merrill J Egorin; Manuel Fernandez; Donald L Trump; Ramesh K Ramanathan
A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors.
Investigational new drugs 2011;29(6):1420-5.
2011: Whitney P Caron; Harvey Clewell; Whitney L Davis; Robert Dedrick; Ramesh K Ramanathan; Jan H Schellens; Margaret Tonda; Ning Yu; Jos H Beijnen; William C Zamboni
Allometric scaling of pegylated liposomal anticancer drugs.
Journal of pharmacokinetics and pharmacodynamics 2011;38(5):653-69.
2011: Alexandra M Dulude; Nedra Harrison; Joyce D'Souza; Ramesh K Ramanathan
Development of breast cancer in a 21-year-old childhood Wilms' tumor survivor with a BRCA1 2634delC mutation.
Clinical breast cancer 2011;11(4):268-9.
2011: Raoul Tibes; Daniel Von Hoff; Jay H Yim; R Curtis Bay; Martin A Benjamin; Raysenia L James; Barbara F Piper; Ramesh K Ramanathan; Jessica A Smith; Mitesh J Borad
Patient willingness to undergo pharmacodynamic and pharmacokinetic tests in early phase oncology trials.
Cancer 2011;117(14):3276-83.
2011: Nash S Moawad; Ramesh K Ramanathan; Richard Guido; Suketu Mansuria; Ted Lee
Comparison of laparoscopic anterior discoid resection and laparoscopic low anterior resection of deep infiltrating rectosigmoid endometriosis.
JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons 2011;15(3):331-8.
2011: Rajesh Sehgal; Herbert Zeh; Amy Schmotzer; Edward P Balaban; Theodore L Crandall; Patrick Kane; Barry C Lembersky; Richard A Pinkerton; Douglas M Potter; Kiran K Rajasenan; Ramesh K Ramanathan
A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer.
Clinical colorectal cancer 2011;10(2):117-20.
2011: William C Zamboni; Lauren J Maruca; Sandra Strychor; Beth A Zamboni; Suresh Ramalingam; Robert P Edwards; Jk Kim; Yj Bang; Hy Lee; David M Friedland; Ronald G Stoller; Chandra P Belani; Ramesh K Ramanathan
Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors.
Journal of liposome research 2011;21(2):158-65.
2011: Glen J Weiss; Jeffrey R Infante; E Gabriela Chiorean; Mitesh J Borad; Johanna C Bendell; Julian R Molina; Raoul Tibes; Ramesh K Ramanathan; Karen Lewandowski; Suzanne F Jones; Mario Lacouture; Virginia K Langmuir; Hank Lee; Stew Kroll; Howard A Burris
Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(9):2997-3004.
2011: Philip Q Bao; Ramesh K Ramanathan; Alyssa Krasinkas; Nathan Bahary; Barry C Lembersky; David L Bartlett; Steven J Hughes; Kenneth K Lee; A James Moser; Herbert J Zeh
Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer.
Annals of surgical oncology 2011;18(4):1122-9.
2011: Anne M Traynor; James P Thomas; Ramesh K Ramanathan; Tarak D Mody; Dona Alberti; George Wilding; Howard H Bailey
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies.
Investigational new drugs 2011;29(2):316-22.
2011: Ramesh K Ramanathan; James Abbruzzese; Tomislav Dragovich; Lynn Kirkpatrick; Jose M Guillen; Amanda F Baker; Linda A Pestano; Sylvan Green; Daniel Von Hoff
A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination.
Cancer chemotherapy and pharmacology 2011;67(3):503-9.
2011: Kyle D Holen; Chandra P Belani; George Wilding; Suresh Ramalingam; Jennifer Volkman; Ramesh K Ramanathan; Lakshmi S Vasist; Carolyn J Bowen; Jeffrey P Hodge; Mohammed M Dar; Peter T C Ho
A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose.
Cancer chemotherapy and pharmacology 2011;67(2):447-54.
2010: Sonali Ganguly; Shane LeBeau; Kim Pierce; Ramesh K Ramanathan; Rose Salata
Multiple paragangliomas in a pregnant patient with a succinate dehydrogenase B mutation.
Postgraduate medicine 2010;122(6):46-50.
2010: Howard L McLeod; Daniel J Sargent; Sharon Marsh; Erin M Green; Cristi R King; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Stephen N Thibodeau; Axel Grothey; Roscoe F Morton; Richard M Goldberg
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3227-33.
2010: Ramesh K Ramanathan; M L Rothenberg; A de Gramont; C Tournigand; R M Goldberg; S Gupta; T André
Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(4):754-8.
2010: Ramesh K Ramanathan; Merrill J Egorin; Charles Erlichman; Scot C Remick; Suresh S Ramalingam; Cynthia Naret; Julianne L Holleran; Cynthia J Teneyck; S Percy Ivy; Chandra P Belani
Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(9):1520-6.
2010: Rajesh Sehgal; Wassim McHayleh; Jodie Alton Reider; Ayeesha Cheema; Ramesh K Ramanathan
Adenocarcinoma of colon presenting as Cushing's syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(8):e126-7.
2010: Shelly S Lo; Alok A Khorana; Milind Javle; Sheryl Simon; Gauri Kiefer; Kiran Rajasenan; Hong Wang; Alexander Hantel; Michelle Shayne; Jimmy Hwang; Amy Schmotzer; Ramesh K Ramanathan
A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas.
Oncology 2010;78(2):125-9.
2010: William B Inabnet; Steven H Belle; Marc Bessler; Anita Courcoulas; Patchen Dellinger; Luis Garcia; James Mitchell; Brant Oelschlager; Robert W O'rourke; John Pender; Alfons Pomp; Walter Pories; Ramesh K Ramanathan; Abdus Wahed; Bruce M Wolfe
Comparison of 30-day outcomes after non-LapBand primary and revisional bariatric surgical procedures from the Longitudinal Assessment of Bariatric Surgery study.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2010;6(1):22-30.
2010: Tara Iyengar; Ramesh K Ramanathan; Philip J Gold
What's causing this woman's chest pain?
Gastroenterology 2010;138(1):e1-2.
2009: Afshin Dowlati; James Posey; Ramesh K Ramanathan; Linda Rath; Pingfu Fu; Amitabh Chak; Smitha Krishnamurthi; Joanna Brell; Stephen Ingalls; Charles L Hoppel; Percy Ivy; Scot C Remick
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
Cancer chemotherapy and pharmacology 2009;65(1):73-8.
2009: William C Zamboni; Sandra Strychor; L Maruca; Sakkaraiappan Ramalingam; B A Zamboni; H Wu; D M Friedland; R P Edwards; R G Stoller; Chandra P Belani; Ramesh K Ramanathan
Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies.
Clinical pharmacology and therapeutics 2009;86(5):519-26.
2009: Ramesh K Ramanathan; Chandra P Belani; Deepti A Singh; Michael Tanaka; Heinz-Josef Lenz; Yun Yen; Hedy L Kindler; Syma Iqbal; Jeff Longmate; Philip C Mack; Georg Lurje; Regina Gandour-Edwards; Janet Dancey; David R Gandara
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
Cancer chemotherapy and pharmacology 2009;64(4):777-83.
2009: William C Zamboni; Sakkaraiappan Ramalingam; David M Friedland; Robert P Edwards; Ronald G Stoller; Sandra Strychor; Lauren Maruca; Beth A Zamboni; Chandra P Belani; Ramesh K Ramanathan
Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1466-72.
2009: Karthik Venkatakrishnan; Michael Rader; Ramesh K Ramanathan; Suresh Ramalingam; Eric Chen; William Riordan; William Trepicchio; Michael Cooper; Michael Karol; Lisa von Moltke; Rachel Neuwirth; Merrill Egorin; Gurkamal Chatta
Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: a prospective, multicenter, open-label, randomized, two-way crossover drug-drug interaction study.
Clinical therapeutics 2009;31 Pt 2():2444-58.
2009: Joanna M Brell; Khalid Matin; Terry Evans; Robert L Volkin; Gauri J Kiefer; James J Schlesselman; Shelley Dranko; Linda Rath; Amy Schmotzer; Diana Lenzner; Ramesh K Ramanathan
Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer.
Oncology 2009;76(4):270-4.
2008: Hanna Sanoff; Daniel J Sargent; Megan E Campbell; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Richard M Goldberg
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5721-7.
2008: Ramesh K Ramanathan
Alternative dosing schedules for cetuximab: a role for biweekly administration?
Clinical colorectal cancer 2008;7(6):364-8.
2008: Paul A Thodiyil; Panduranga Yenumula; Rogula Tomasz; Piotr J Gorecki; Bashar Fahoum; William Gourash; Ramesh K Ramanathan; Samer G Mattar; Dilip Shinde; Vincent C Arena; Leslie Wise; Philip R Schauer
Selective nonoperative management of leaks after gastric bypass: lessons learned from 2675 consecutive patients.
Annals of surgery 2008;248(5):782-92.
2008: Saima Sharif; Ramesh K Ramanathan; Douglas Potter; Kathleen Cieply; Alyssa M Krasinskas
HER2 gene amplification and chromosome 17 copy number do not predict survival of patients with resected pancreatic adenocarcinoma.
Digestive diseases and sciences 2008;53(11):3026-32.
2008: Yun Yen; Dean W Lim; Vincent Chung; Robert J Morgan; Lucille A Leong; Stephen I Shibata; Lawrence D Wagman; Stephen D Wagman; Howard Marx; Peiguo G Chu; Jeff Longmate; Heinz-Josef Lenz; Ramesh K Ramanathan; Chandra P Belani; David R Gandara
Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial.
American journal of clinical oncology 2008;31(4):317-22.
2008: Howard Hochster; Lowell L Hart; Ramesh K Ramanathan; Barrett H Childs; John D Hainsworth; Allen L Cohn; Lucas Wong; Louis Fehrenbacher; Yousif Abubakr; M Wasif Saif; Lee Schwartzberg; Eric Hedrick
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(21):3523-9.
2008: Sakkaraiappan Ramalingam; Merrill J Egorin; Ramesh K Ramanathan; Scot C Remick; Rachel Sikorski; Theodore F Lagattuta; Gurkamal S Chatta; David M Friedland; Ronald G Stoller; Douglas M Potter; S Percy Ivy; Chandra P Belani
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3456-61.
2008: Ramesh K Ramanathan; Georg A Bjarnason; Stephen A Bernard; Philip Desimone; Theodore Braich; Joseph P Evars; William J M Hrushesky; Jacques Jolivet
A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer.
Clinical colorectal cancer 2008;7(2):134-9.
2008: Ramesh K Ramanathan; Joel Picus; Haralambos Raftopoulos; Stephen A Bernard; A Craig Lockhart; Gary Frenette; John Macdonald; Susan Melin; Daniel Berg; Frank Brescia; Howard Hochster; Allen Cohn
A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer.
Cancer chemotherapy and pharmacology 2008;61(3):453-8.
2008: Joseph Gibbons; Merrill J Egorin; Ramesh K Ramanathan; Pingfu Fu; Daniel Mulkerin; Stephen Shibata; Chris H Takimoto; Sridhar Mani; Patricia M LoRusso; Jean L Grem; Anna Pavlick; Heinz-Josef Lenz; Susan M Flick; Sherrie Reynolds; Theodore F Lagattuta; Robert A Parise; Yanfeng Wang; Anthony J Murgo; S Percy Ivy; Scot C Remick
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):570-6.
2008: Ramesh K Ramanathan; Merrill J Egorin; Chris H Takimoto; Scot C Remick; James Doroshow; Patricia M LoRusso; Daniel Mulkerin; Jean L Grem; Anne Hamilton; Anthony J Murgo; Douglas M Potter; Chandra P Belani; Michael J Hayes; Bin Peng; S Percy Ivy
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):563-9.
2008: Axel Grothey; Eric E Hedrick; Robert D Mass; Somnath Sarkar; Sam Suzuki; Ramesh K Ramanathan; Herbert I Hurwitz; Richard M Goldberg; Daniel J Sargent
Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):183-9.
2007: Kambiz Zainabadi; Ramesh K Ramanathan
Intussusception after laparoscopic Roux-en-Y gastric bypass.
Obesity surgery 2007;17(12):1619-23.
2007: Daniel R Cottam; Spencer Holover; Samer G Mattar; Sunil K Sharma; Walt Medlin; Ramesh K Ramanathan; Philip R Schauer
The mini-fellowship concept: a six-week focused training program for minimally invasive bariatric surgery.
Surgical endoscopy 2007;21(12):2237-9.
2007: Carol A McCloskey; Gautam Ramani; Michael A Mathier; Philip R Schauer; George M Eid; Samer G Mattar; Anita P Courcoulas; Ramesh K Ramanathan
Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2007;3(5):503-7.
2007: Claudia Hriesik; Ramesh K Ramanathan; Steven J Hughes
Update for surgeons: recent and noteworthy changes in therapeutic regimens for cancer of the colon and rectum.
Journal of the American College of Surgeons 2007;205(3):468-78 (Quiz 524).
2007: Chris H Takimoto; Martin A Graham; Graham Lockwood; Chee M Ng; Andrew Goetz; Dennis Greenslade; Scot C Remick; Sunil Sharma; Sridhar Mani; Ramesh K Ramanathan; Timothy W Synold; James Doroshow; Anne Hamilton; Daniel Mulkerin; Percy Ivy; Merrill J Egorin; Jean L Grem
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(16):4832-9.
2007: Grace K Dy; James E Krook; Erin M Green; Daniel J Sargent; Thierry Delaunoit; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Barbara A Pockaj; Robert P Sticca; Steven R Alberts; Henry C Pitot; Richard M Goldberg
Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3469-74.
2007: Amanda C Ashley; Daniel J Sargent; Steven R Alberts; Axel Grothey; Megan E Campbell; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Richard M Goldberg
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.
Cancer 2007;110(3):670-7.
2007: Timothy W Synold; Chris H Takimoto; James Doroshow; David R Gandara; Sridhar Mani; Scot C Remick; Daniel Mulkerin; Anne Hamilton; Sunil Sharma; Ramesh K Ramanathan; Heinz-Josef Lenz; Martin Graham; Jeff Longmate; Bennett M Kaufman; Percy Ivy
Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(12):3660-6.
2007: Sakkaraiappan Ramalingam; Robert A Parise; Ramesh K Ramanathan; Ramesh K Ramananthan; Theodore F Lagattuta; Lori A Musguire; Ronald G Stoller; Douglas M Potter; Athanassios Argiris; James A Zwiebel; Merrill J Egorin; Chandra P Belani
Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(12):3605-10.
2007: J Philip Kuebler; H Samuel Wieand; Michael J O'Connell; Roy E Smith; Linda H Colangelo; Greg Yothers; Nicholas J Petrelli; Michael P Findlay; Thomas E Seay; James N Atkins; John L Zapas; J Wendall Goodwin; Louis Fehrenbacher; Ramesh K Ramanathan; BA Conley; Patrick J Flynn; Gamini Soori; Lauren K Colman; Edward A Levine; Keith S Lanier; Norman Wolmark
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2198-204.
2007: Julie L Eiseman; Jianxia Guo; Ramesh K Ramanathan; Chandra P Belani; David B Solit; Howard I Scher; S Percy Ivy; Eleanor G Zuhowski; Merrill J Egorin
Evaluation of plasma insulin-like growth factor binding protein 2 and Her-2 extracellular domain as biomarkers for 17-allylamino-17-demethoxygeldanamycin treatment of adult patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2121-7.
2007: Ramesh K Ramanathan; D Lynn Kirkpatrick; Chandra P Belani; David M Friedland; Sylvan B Green; H-H Sherry Chow; Catherine A Cordova; Steven P Stratton; Elizabeth R Sharlow; Amanda Baker; Tomislav Dragovich
A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2109-14.
2007: Ramesh K Ramanathan; Merrill J Egorin; Julie L Eiseman; Sakkaraiappan Ramalingam; David M Friedland; Sanjiv S Agarwala; S Percy Ivy; Douglas M Potter; Gurkamal S Chatta; Eleanor G Zuhowski; Ronald G Stoller; Cynthia Naret; Jianxia Guo; Chandra P Belani
Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1769-74.
2007: Joy Collins; Samer G Mattar; Faisal G Qureshi; Juanita Warman; Ramesh K Ramanathan; Philip R Schauer; George M Eid
Initial outcomes of laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2007;3(2):147-52.
2007: Richard M Goldberg; Mace L Rothenberg; Eric Van Cutsem; Al B Benson; Charles D Blanke; Robert B Diasio; Axel Grothey; Heinz-Josef Lenz; Neal J Meropol; Ramesh K Ramanathan; Carlos H Roberto Becerra; Rita Wickham; Delma Armstrong; Carol Viele
The continuum of care: a paradigm for the management of metastatic colorectal cancer.
The oncologist 2007;12(1):38-50.
2006: Manish A Shah; Ramesh K Ramanathan; David H Ilson; Alissa Levnor; David R D'Adamo; Eileen O'Reilly; Archie N Tse; Robin Trocola; Lawrence H Schwartz; Marinela Capanu; Gary K Schwartz; David P Kelsen
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5201-6.
2006: Shelley Dranko; Connie Kinney; Ramesh K Ramanathan
Ocular toxicity related to cetuximab monotherapy in patients with colorectal cancer.
Clinical colorectal cancer 2006;6(3):224-5.
2006: William C Zamboni; Ramesh K Ramanathan; howard mcleod; Sridhar Mani; Douglas M Potter; Sandra Strychor; Lauren J Maruca; Cristi R King; Laura L Jung; Robert A Parise; Merrill J Egorin; Todd A Davis; Sharon Marsh
Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes.
Investigational new drugs 2006;24(5):393-401.
2006: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven Alberts
Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3347-53.
2006: Hitendra Patel; Ronald G Stoller; Miklos Auber; Douglas Potter; Chao Cai; William C Zamboni; Gauri Kiefer; Khalid Matin; Amy Schmotzer; Ramesh K Ramanathan
Phase II study of rubitecan, an oral camptothecin in patients with advanced colorectal cancer who have failed previous 5-fluorouracil based chemotherapy.
Investigational new drugs 2006;24(4):359-63.
2006: Jeffrey L Lord; Daniel R Cottam; Ramsey M Dallal; Samer G Mattar; A R Watson; J M Glasscock; Ramesh K Ramanathan; George M Eid; Philip R Schauer
The impact of laparoscopic bariatric workshops on the practice patterns of surgeons.
Surgical endoscopy 2006;20(6):929-33.
2006: Daniel R Cottam; Faisal G Qureshi; Samer G Mattar; S Sharma; Spencer Holover; Gianluca Bonanomi; Ramesh K Ramanathan; Philip R Schauer
Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity.
Surgical endoscopy 2006;20(6):859-63.
2006: Sunil K Sharma; Jerry McCauley; Daniel R Cottam; Samer G Mattar; Spencer Holover; Ramsey M Dallal; Jeff Lord; Omar Danner; Ramesh K Ramanathan; George M Eid; Philip R Schauer
Acute changes in renal function after laparoscopic gastric surgery for morbid obesity.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2006;2(3):389-92.
2006: Firas N Shadad; Ramesh K Ramanathan
17-dimethylaminoethylamino-17-demethoxygeldanamycin in patients with advanced-stage solid tumors and lymphoma: a phase I study.
Clinical lymphoma & myeloma 2006;6(6):500-1.
2006: Ramesh K Ramanathan; Marwan G Fakih; Sridhar Mani; Melvin Deutsch; Raymond P Perez; Mark A Ritter; Julie L Eiseman; S Percy Ivy; Donald L Trump; Chandra P Belani; Robert A Parise; Douglas M Potter; Merrill J Egorin
Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers.
Cancer chemotherapy and pharmacology 2006;57(4):465-74.
2006: Amanda F Baker; Tomislav Dragovich; Wendy R Tate; Ramesh K Ramanathan; Denise Roe; Chiu-Hsieh Hsu; D Lynn Kirkpatrick; Garth Powis
The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma.
The Journal of laboratory and clinical medicine 2006;147(2):83-90.
2005: Mace L Rothenberg; Bonnie J Lafleur; Donna E Levy; M Kay Washington; Sherry L Morgan-Meadows; Ramesh K Ramanathan; Jordan D Berlin; Al B Benson; Robert J Coffey
Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9265-74.
2005: Howard Hochster; Erika Kettner; Hendrik Kroning; Klaus Becker; Florian Lordick; Ramesh K Ramanathan; John Macdonald; Shengyan Hong; William John; Hans-Joachim Schmoll
Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced colorectal cancer.
Clinical colorectal cancer 2005;5(4):257-62.
2005: Georgios I Papachristou; Karen E Schoedel; Ramesh K Ramanathan; Mordecai Rabinovitz
Clonorchis sinensis-associated cholangiocarcinoma: a case report and review of the literature.
Digestive diseases and sciences 2005;50(11):2159-62.
2005: Khalid Matin; Samuel A Jacobs; Thomas Richards; Michael K Wong; Martin Earle; Terry Evans; Monica Troetschel; William Ferri; David M Friedland; Richard Pinkerton; Robert Volkin; Samuel Wieand; Ramesh K Ramanathan
A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer.
American journal of clinical oncology 2005;28(5):439-44.
2005: Samer G Mattar; Laura M Velcu; Mordecai Rabinovitz; Anthony J Demetris; Alyssa M Krasinskas; Emma Barinas-Mitchell; George M Eid; Ramesh K Ramanathan; Debra S Taylor; Philip R Schauer
Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome.
Annals of surgery 2005;242(4):610-7; discussion 618-20.
2005: Helmut Oettle; D Richards; Ramesh K Ramanathan; J L van Laethem; M Peeters; M Fuchs; A Zimmermann; W John; Daniel Von Hoff; M Arning; H L Kindler
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(10):1639-45.
2005: William C Zamboni; Laura L Jung; Merrill J Egorin; Deborah R Hamburger; Erin Joseph; Ruzhi Jin; Sandra Strychor; Ramesh K Ramanathan; Julie L Eiseman
Relationship between plasma exposure of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite and antitumor response in mice bearing human colon carcinoma xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4867-74.
2005: Jeffrey A Meyerhardt; Jeffrey A Sloan; Daniel J Sargent; Richard M Goldberg; Michael Pollak; Roscoe F Morton; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Charlie S Fuchs
Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1402-10.
2005: Shelly S Lo; Georgios I Papachristou; Sydney D Finkelstein; William P Conroy; Wolfgang H Schraut; Ramesh K Ramanathan
Neoadjuvant imatinib in gastrointestinal stromal tumor of the rectum: report of a case.
Diseases of the colon and rectum 2005;48(6):1316-9.
2005: Ramesh K Ramanathan; Donald L Trump; Julie L Eiseman; Chandra P Belani; Sanjiv S Agarwala; Eleanor G Zuhowski; Jing Lan; Douglas M Potter; S Percy Ivy; Sakkaraiappan Ramalingam; Adam Brufsky; Michael K K Wong; Susan Tutchko; Merrill J Egorin
Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3385-91.
2005: Ramesh K Ramanathan; Sakkaraiappan Ramalingam; Merrill J Egorin; Chandra P Belani; Douglas M Potter; Marwan G Fakih; Laura L Jung; Sandra Strychor; Samuel A Jacobs; David M Friedland; Dong M Shin; Gurkamal S Chatta; Susan Tutchko; William C Zamboni
Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies.
Cancer chemotherapy and pharmacology 2005;55(4):354-60.
2005: Thierry Delaunoit; Steven R Alberts; Daniel J Sargent; Erin Green; Richard M Goldberg; James E Krook; C Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Roscoe F Morton; Brian P Findlay
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(3):425-9.
2005: Xueyu Chen; Robert R Bies; Ramesh K Ramanathan; Eleanor G Zuhowski; Donald L Trump; Merrill J Egorin
Population pharmacokinetic analysis of 17-(allylamino)-17-demethoxygeldanamycin (17AAG) in adult patients with advanced malignancies.
Cancer chemotherapy and pharmacology 2005;55(3):237-43.
2005: Ramesh K Ramanathan; Kenneth M Lee; John R McKolanis; Elizabeth Hitbold; Wolfgang H Schraut; A James Moser; Elizabeth Warnick; Theresa Whiteside; Jennifer Osborne; Hyoung Kim; Roger Day; Monica Troetschel; Olivera J Finn
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer.
Cancer immunology, immunotherapy : CII 2005;54(3):254-64.
2004: Cathy Eng; Ramesh K Ramanathan; Ramesh K Ramathan; Michael K Wong; Scot C Remick; Lanting Dai; Kurombi Wade-Oliver; Sridhar Mani; Hedy L Kindler
A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma.
American journal of clinical oncology 2004;27(6):565-9.
2004: Laura L Jung; Ramesh K Ramanathan; Merrill J Egorin; Ruzhi Jin; Chandra P Belani; Douglas M Potter; Sandra Strychor; Donald L Trump; Christine M Walko; Marwan G Fakih; William C Zamboni
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors.
Cancer chemotherapy and pharmacology 2004;54(6):487-96.
2004: Sakkaraiappan Ramalingam; Theodore F Lagattuta; Merrill J Egorin; Michael J Hayes; Ramesh K Ramanathan
Biliary excretion of imatinib mesylate and its metabolite CGP 74588 in humans.
Pharmacotherapy 2004;24(9):1232-5.
2004: William C Zamboni; Laura L Jung; Merrill J Egorin; Douglas M Potter; David M Friedland; Chandra P Belani; Sanjiv S Agarwala; Michael M W Wong; Marwan G Fakih; Donald L Trump; Ruzhi Jin; Sandra Strychor; Michael Vozniak; Monica Troetschel; Ramesh K Ramanathan
Phase I and pharmacologic study of intermittently administered 9-nitrocamptothecin in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5058-64.
2004: Ramesh K Ramanathan; Jimmy J Hwang; William C Zamboni; Frank A Sinicrope; Howard Safran; Michael K Wong; Martin Earle; Adam Brufsky; Terry Evans; Monica Troetschel; Christine M Walko; Roger Day; Helen X Chen; Sydney Finkelstein
Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trial.
Cancer investigation 2004;22(6):858-65.
2004: Howard Safran; David A Iannitti; Ramesh K Ramanathan; Jonathan D Schwartz; Margaret Steinhoff; Chris Nauman; Paul J Hesketh; ritesh rathore; Robert Wolff; Umadevi Tantravahi; T Marilyn Hughes; Chris Maia; Terry Pasquariello; Lisa Goldstein; Thomas King; James Y Tsai; Teresa Kennedy
Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu.
Cancer investigation 2004;22(5):706-12.
2004: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven R Alberts
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):23-30.
2003: Philip R Schauer; Bartolome Burguera; Sayeed Ikramuddin; Daniel R Cottam; William Gourash; Giselle G Hamad; George M Eid; Samer G Mattar; Ramesh K Ramanathan; Emma Barinas-Mitchel; R Harsha Rao; Lewis Kuller; David Kelley
Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.
Annals of surgery 2003;238(4):467-84; discussion 84-5.
2003: Shelly S Lo; Andrew M Yeager; Robert L Peel; William E Katz; Ramesh K Ramanathan
Multimodality treatment in a case of primary cardiac lymphoma.
Clinical lymphoma 2003;4(2):112-4.
2003: Philip R Schauer; Sayeed Ikramuddin; Giselle G Hamad; George M Eid; Samer G Mattar; Daniel R Cottam; Ramesh K Ramanathan; William Gourash
Laparoscopic gastric bypass surgery: current technique.
Journal of laparoendoscopic & advanced surgical techniques. Part A 2003;13(4):229-39.
2003: Chris H Takimoto; Scot C Remick; Sunil Sharma; Sridhar Mani; Ramesh K Ramanathan; James Doroshow; Anne Hamilton; Daniel Mulkerin; Martin Graham; Graham F Lockwood; Percy Ivy; Merrill J Egorin; Dennis Greenslade; Andrew Goetz; Jean L Grem
Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working group.
Seminars in oncology 2003;30(4 Suppl 15):20-5.
2003: James Doroshow; Timothy W Synold; David R Gandara; Sridhar Mani; Scot C Remick; Daniel Mulkerin; Anne Hamilton; Sunil Sharma; Ramesh K Ramanathan; Heinz-Josef Lenz; Martin Graham; Jeff Longmate; Chris H Takimoto; Percy Ivy
Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group.
Seminars in oncology 2003;30(4 Suppl 15):14-9.
2003: Ramesh K Ramanathan; jeffrey clark; Nancy Kemeny; Heinz-Josef Lenz; Kim O Gococo; Daniel G Haller; Edith P Mitchell; Carl G Kardinal
Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2904-11.
2003: Chris H Takimoto; Scot C Remick; Sunil Sharma; Sridhar Mani; Ramesh K Ramanathan; James Doroshow; Anne Hamilton; Daniel Mulkerin; Martin Graham; Graham F Lockwood; Percy Ivy; Merrill J Egorin; Barbara Schuler; Dennis Greenslade; Andrew Goetz; Ronald Knight; Rebecca Thomas; Brian P Monahan; William Dahut; Jean L Grem
Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(14):2664-72.
2003: Robert A Parise; Ramesh K Ramanathan; Michael J Hayes; Merrill J Egorin
Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;791(1-2):39-44.
2003: Mace L Rothenberg; Amit Oza; Robert H Bigelow; Jordan D Berlin; John L Marshall; Ramesh K Ramanathan; Lowell L Hart; Sunil Gupta; Carlos A Garay; Brent G Burger; Nathalie Le Bail; Daniel G Haller
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2059-69.
2003: Robert A Parise; Ramesh K Ramanathan; William C Zamboni; Merrill J Egorin
Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;783(1):231-6.
2003: Michael Turner; John R McKolanis; Ramesh K Ramanathan; david whitcomb; Olivera J Finn
Mucins in gastrointestinal cancers.
Cancer chemotherapy and biological response modifiers 2003;21():259-74.
2002: Ramesh K Ramanathan; Douglas M Potter; Chandra P Belani; Samuel A Jacobs; Stefan Gravenstein; Felix Lim; Hyoung Kim; Steven Savona; Terry Evans; Dianne Buchbarker; Mary B Simon; Jane K Depee; Donald L Trump
Randomized trial of influenza vaccine with granulocyte-macrophage colony-stimulating factor or placebo in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4313-8.
2002: Melvin Deutsch; Michael R Wollman; Ramesh K Ramanathan; Joshua Rubin
Rectal cancer twenty-one years after treatment of childhood Hodgkin disease.
Medical and pediatric oncology 2002;38(4):280-1.
2002: David Blumberg; Ramesh K Ramanathan
Treatment of colon and rectal cancer.
Journal of clinical gastroenterology 2002;34(1):15-26.
2001: Marwan G Fakih; Marie C DeFrances; N Paul Ohori; Ramesh K Ramanathan
Unusual tumors involving the head and neck region: case 1. Angiosarcoma of the scalp.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(21):4173-4.
2001: Ramesh K Ramanathan; A Cnaan; Richard G Hahn; P P Carbone; D G Haller
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(8):1139-43.
2000: Brian J Delauter; Ramesh K Ramanathan; Merrill J Egorin; Lori Stover; Eleanor G Zuhowski; W Plunkett; William C Zamboni
Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascites.
Pharmacotherapy 2000;20(10):1204-7.
2000: Philip R Schauer; Sayeed Ikramuddin; William Gourash; Ramesh K Ramanathan; James D Luketich
Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity.
Annals of surgery 2000;232(4):515-29.
2000: Ramesh K Ramanathan; Joshua Rubin; N Paul Ohori; Chandra P Belani
Dramatic response of adult wilms tumor to paclitaxel and cisplatin.
Medical and pediatric oncology 2000;34(4):296-8.
1999: Ramesh K Ramanathan; S Lipsitz; RF Asbury; R Qazi; B R Greenberg; D G Haller
Phase II trial of trimetrexate for patients with advanced gastric carcinoma: an Eastern Cooperative Oncology Group study (E1287).
Cancer 1999;86(4):572-6.
1999: Chandra P Belani; C M Kearns; Eleanor G Zuhowski; K Erkmen; D Hiponia; D Zacharski; C Engstrom; Ramesh K Ramanathan; Mary Jo Capozzoli; Joseph Aisner; Merrill J Egorin
Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):676-84.
1999: Melvin Deutsch; Maury Rosenstein; Ramesh K Ramanathan
Pancreatic cancer in a young adult after treatment for Hodgkin's disease.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1999;11(4):280-2.
1998: Chandra P Belani; Ramesh K Ramanathan
Combined-modality treatment of locally advanced non-small cell lung cancer: incorporation of novel chemotherapeutic agents.
Chest 1998;113(1 Suppl):53S-60S.
1997: Chandra P Belani; J D Luketich; R J Landreaneau; R Kim; Ramesh K Ramanathan; R Day; Peter F Ferson; Robert J Keenan; M Posner; J Seeger; Barry C Lembersky
Efficacy of cisplatin, 5-fluorouracil, and paclitaxel regimen for carcinoma of the esophagus.
Seminars in oncology 1997;24(6 Suppl 19):S19-89-S19-92.
1997: Ramesh K Ramanathan; Chandra P Belani
Chemotherapy for advanced non-small cell lung cancer: past, present, and future.
Seminars in oncology 1997;24(4):440-54.
1997: Ramesh K Ramanathan; J M Thomas
Infantile (desmoid-type) fibromatosis of the parotid gland.
The Journal of laryngology and otology 1997;111(7):669-70.
1997: Ramesh K Ramanathan; Darrell J Triulzi; Theodore F Logan
Transfusion-related acute lung injury following random donor platelet transfusion: a report of two cases.
Vox sanguinis 1997;73(1):43-5.
1996: Chandra P Belani; Joseph Aisner; D Hiponia; Ramesh K Ramanathan
Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I study.
Seminars in oncology 1996;23(5 Suppl 12):19-21.
1996: Ramesh K Ramanathan; V V Reddy; J M Holbert; Chandra P Belani
Pulmonary infiltrates following administration of paclitaxel.
Chest 1996;110(1):289-92.
1996: Ramesh K Ramanathan; Chandra P Belani
Transient pulmonary infiltrates: a hypersensitivity reaction to paclitaxel.
Annals of internal medicine 1996;124(2):278.
1995: C M Kearns; Chandra P Belani; K Erkmen; M Zuhowski; D Hiponia; D Zacharski; C Engstrom; Ramesh K Ramanathan; M R Trenn; Joseph Aisner
Pharmacokinetics of paclitaxel and carboplatin in combination.
Seminars in oncology 1995;22(5 Suppl 12):1-4; discussion 5-7.